en · de · es · fr · pt
creatine-notes.peptides6823.com › News › Research History And Clinical Assessment — What the Evidence Shows

Research History And Clinical Assessment — What the Evidence Shows

By Editorial Desk · published 2025-08-18 · last reviewed 2025-09-04 · News

A practical reference on immunomodulatory peptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-09-04. Anything still debated is marked as such rather than presented as settled.

Research History and Clinical Assessment

Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.

Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.

Background, Structure, and Mechanism

Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.

Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.

Thymosin-alpha-1 at a glance

PropertyValueNotes
First described1977Reported as a component of thymosin fraction 5
Sequence length28 amino acidsN-terminal residue is acetylated
Net charge at neutral pHNegativeReflects a high proportion of acidic residues
Principal studied usesChronic hepatitis B and vaccine adjuvantResearch uses outnumber approved indications
Regulatory statusApproved in a limited number of countriesNot approved in the United States or most of Europe

分子身份与天然来源

胸腺素α1(thymosin alpha 1,Tα1)是一种由28个氨基酸组成的酸性肽,N端被乙酰化,分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离,属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守,提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置,并非表示亚型编号。它既存在于胸腺,也存在于脾脏和淋巴结等免疫组织。

20世纪70年代,研究者从胸腺提取物中纯化出多种小肽,Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤,产量低且成分复杂。随着固相肽合成技术成熟,实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上,并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。

Related pages on this site

Molecular Background and Identity

Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.

Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.

Notes from published material

Smashburger's menu focuses primarily on burgers, chicken sandwiches, black bean burgers and salads, with a variety of toppings and options that can be customized to a customer's taste. The company also offers a number of sides, including french fries, sweet potato fries, fried onions, and fried pickles, and "smash fries" which are topped with rosemary and olive oil. Many of the sandwiches are topped with an in-house "smash sauce" made with mayonnaise, mustard, pickles and lemon juice. Smashburger's main dessert item is a milkshake made with Häagen-Dazs ice cream. About 20 milkshakes are sold per 100 burgers. The chain experimented with a breakfast menu for a time but it found this to be unprofitable, accounting for just 10 percent of its revenue but 30 percent of expenses. Some of its specialized locations such as those in casinos do continue to offer breakfast menus. Smashburger also attempted a system for customers to fill out menu cards as they waited in line which was not successful.

Reproductive Medicine: In 2024, a study demonstrated that SeV-mediated RNA delivery of the Kitl gene successfully re-initiated oogenesis and restored fertility in congenitally and chemotherapy-induced infertile female mice without genomic integration. Oncology: A 2024 study found that SeV provides more robust and consistent gene delivery into human pancreatic cancer cells than adeno-associated virus (AAV) or lentiviral vectors, regardless of tumor subtype. CRISPR-Cas9 Delivery: A next-generation "interferon-silent" and temperature-sensitive (ts) SeV platform was introduced in 2024, achieving over 90% editing efficiency in primary human hematopoietic stem and progenitor cells (HSPCs). In 2025, this ts SeV platform was further applied to deliver CRISPR/Cas9 for precise engineering of the human cytomegalovirus (HCMV) genome, bypassing traditional bacterial artificial chromosome (BAC) constraints and enabling editing in diverse cell types.

Inflammatory abnormalities are a large group of disorders that underlie a vast variety of human diseases. The immune system is often involved with inflammatory disorders, as demonstrated in both allergic reactions and some myopathies, with many immune system disorders resulting in abnormal inflammation. Non-immune diseases with causal origins in inflammatory processes include cancer, atherosclerosis, and ischemic heart disease. Examples of disorders associated with inflammation include:

Sources: en.wikipedia.org

Background from the literature

24395Am + 2210Ne → 265−x105 + x n (x = 4, 5) After observing the alpha decays of element 105, the researchers aimed to observe spontaneous fission (SF) of the element and study the resulting fission fragments. They published a paper in February 1970, reporting multiple examples of two such activities, with half-lives of 14 ms and 2.2±0.5 s. They assigned the former activity to 242mfAm and ascribed the latter activity to an isotope of element 105. They suggested that it was unlikely that this activity could come from a transfer reaction instead of element 105, because the yield ratio for this reaction was significantly lower than that of the 242mfAm-producing transfer reaction, in accordance with theoretical predictions. To establish that this activity was not from a (22Ne,xn) reaction, the researchers bombarded a 243Am target with 18O ions; reactions producing 256103 and 257103 showed very little SF activity (matching the established data), and the reaction producing heavier 258103 and 259103 produced no SF activity at all, in line with theoretical data. The researchers concluded that the activities observed came from SF of element 105. In April 1970, a team at Lawrence Berkeley Laboratory (LBL), in Berkeley, California, United States, claimed to have synthesized element 105 by bombarding californium-249 with nitrogen-15 ions, with an alpha activity of 9.1 MeV. To ensure this activity was not from a different reaction, the team attempted other reactions: bombarding 249Cf with 14N, Pb with 15N, and Hg with 15N. They stated no such activity was found in those reactions.

Nicolás Maduro has been criticized for authoritarian rule since Hugo Chávez hand-picked him as the next president of Venezuela in 2013. According to Reuters, "Maduro ruled Venezuela with a heavy hand ... presiding over deep economic and social crises and resisting pressure from domestic opponents and foreign governments for political change", and was "long accused by critics both at home and abroad of being a dictator who jailed or persecuted political opponents and repeatedly staged sham elections". Mark Weisbrot states that Venezuela has faced an economic crisis since the oil glut of the 2010s, due to its export-dependent economy. For years, the US government pressured Maduro, considering him an "illegitimate leader". Unilateral US sanctions on Venezuela began in the 2010s, and escalated through 2025. According to a 2019 report by Mark Weisbrot and Jeffrey Sachs, sanctions caused Venezuela a loss of $38 billion between 2016 and 2019, prevented the government from resolving the crisis using fiscal and monetary policy changes, and in combination with preexisting negative trends resulted in an estimated 40,000 excess deaths between 2017 and 2018. The report's methodology and conclusions were criticized by other economists. Maduro's victory in the 2018 Venezuelan presidential election was disputed and 45 countries did not accept the results, causing a presidential crisis that divided the international community from 2019 to 2023. In May 2020, Venezuelan dissidents backed by Silvercorp USA attempted to infiltrate Venezuela by sea and overthrow Maduro in Operation Gideon.

== Conservation == Parmotrema perlatum has been identified as a species of concern in some regions due to its rarity and declining populations. In Hungary, it has been proposed for 'endangered' status in the Hungarian lichen red list, reflecting its limited distribution and the pressures it faces in its natural habitats there. Similarly, in Ukraine, the species is listed in the Red Data Book of Ukraine with the status of "Rare". Additionally, Parmotrema perlatum is red-listed in Sweden In northern North America, its NatureServe conservation status is designated as "G4", meaning "apparently secure" at the global level. In the United States, it has been assessed as secure in Kentucky and presumed extirpated in Wisconsin, while in Canada, it is considered as vulnerable in British Columbia and Ontario, and critically imperiled in New Brunswick.

Sources: en.wikipedia.org

Reference notes

At temperatures above 350 °C (662 °F), cellulose undergoes thermolysis (also called 'pyrolysis'), decomposing into solid char, vapors, aerosols, and gases such as carbon dioxide. Maximum yield of vapors which condense to a liquid called bio-oil is obtained at 500 °C (932 °F). Semi-crystalline cellulose polymers react at pyrolysis temperatures (350–600 °C (662–1,112 °F)) in a few seconds; this transformation has been shown to occur via a solid-to-liquid-to-vapor transition, with the liquid (called intermediate liquid cellulose or molten cellulose) existing for only a fraction of a second. Glycosidic bond cleavage produces short cellulose chains of two-to-seven monomers comprising the melt. Vapor bubbling of intermediate liquid cellulose produces aerosols, which consist of short chain anhydro-oligomers derived from the melt. Continuing decomposition of molten cellulose produces volatile compounds including levoglucosan, furans, pyrans, light oxygenates, and gases via primary reactions. Within thick cellulose samples, volatile compounds such as levoglucosan undergo 'secondary reactions' to volatile products including pyrans and light oxygenates such as glycolaldehyde.

Louis Hegedus' 16-step racemic total synthesis of Jatraphone involved a Stille-carbonylative cross-coupling as its final step to form the 11-membered macrocycle. Instead of a halide, a vinyl triflate is used there as the coupling partner.

First known as "emanation", the radioactive gas was identified during experiments with radium, thorium oxide, and actinium by Friedrich Ernst Dorn, Rutherford and Owens, and André-Louis Debierne, respectively, and each element's emanation was considered to be a separate substance: radon, thoron, and actinon. Sir William Ramsay and Robert Whytlaw-Gray considered that the radioactive emanations may contain a new element of the noble gas family, and isolated "radium emanation" in 1909 to determine its properties. In 1911, the element Ramsay and Whytlaw-Gray isolated was accepted by the International Commission for Atomic Weights, and in 1923, the International Committee for Chemical Elements and the International Union of Pure and Applied Chemistry (IUPAC) chose radon as the accepted name for the element's most stable isotope, 222Rn; thoron and actinon were also recognized by IUPAC as distinct isotopes of the element. A common source of environmental radon is uranium-containing minerals in the ground. Radon can also occur in ground water, such as spring waters and hot springs. Radon trapped in permafrost may be released by climate-change-induced thawing of permafrosts, and radon may also be released into groundwater and the atmosphere following seismic events leading to earthquakes, which has led to its investigation in the field of earthquake prediction. It is possible to test for radon in buildings, and to use techniques such as sub-slab depressurization for mitigation.

Archeological evidence from Peru shows that cocaine use dates back as far as 8000 B.C.E. Stimulants have been used to treat various conditions, such as narcolepsy, attention deficit hyperactivity disorder (ADHD), obesity, depression, and fatigue. They have also been used as recreational drugs, performance-enhancing substances, cognitive enhancers, and to promote aggression of combatants in wartime.

Sources: en.wikipedia.org

Frequently asked questions

Why are clinical results inconsistent?

Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.

In which countries is thymosin alpha 1 approved?

Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.

How is the peptide characterized in review articles?

Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.

What is thymosin alpha-1 derived from?

It corresponds to the first 28 amino acids of thymosin beta-4, a larger protein found in many tissues. The fragment is acetylated at its N-terminus and is produced synthetically for research and pharmaceutical use. Synthetic and natural forms share the same sequence.

Network